Treatment with controlled-release lovastatin decreases serum concentrations of human β-amyloid (Aβ) peptide
Open Access
- 22 June 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 4 (02) , 127-130
- https://doi.org/10.1017/s1461145701002310
Abstract
The deposition of β-amyloid (Aβ) in neuronal plaques is believed to be crucial for the initiation and progression of Alzheimer's disease (AD). StudieKeywords
This publication has 0 references indexed in Scilit: